Catalyst Wire Dossier Catalyst Wire Dossier

NORA520

· DuKang Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NORA520, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression [Phase 2]

See pricing